Provide Feedback |

Register

Commentary

Emerging Classic

Vulnerability of the medical product supply chain: the wake-up call of COVID-19.

November 25, 2020

Miller FA, Young SB, Dobrow M, et al. BMJ Qual Saf. 2020;30(4):331-335.

View more articles from the same authors.

The COVID-19 pandemic has raised concerns about medical product shortages and demand surges, and the resulting effects on patient safety. This viewpoint discusses medical product supply chain vulnerabilities heightened by the COVID-19 pandemic. The authors summarize the evidence on supply chain resilience and medical product shortage, provide examples to illustrate key vulnerabilities, and discuss reactive and proactive solutions for medical product shortage.

PubMed citation

Related Resources From the Same Author(s)

Factors influencing physician responsiveness to nurse-initiated communication: a qualitative study.

December 2, 2020

Incidence, nature and causes of avoidable significant harm in primary care in England: retrospective case note review.

December 16, 2020

Safe clinical practice for patients hospitalised in mental health wards during a suicidal crisis: qualitative study of patient experiences.

December 23, 2020

Application of human factors to improve usability of clinical decision support for diagnostic decision-making: a scenario-based simulation study.

January 8, 2020

Striving for high reliability in healthcare: a qualitative study of the implementation of a hospital safety programme.

June 22, 2022

Chronic hospital nurse understaffing meets COVID-19: an observational study.

September 9, 2020

We're all in this together: how COVID-19 revealed the co-construction of mindful organising and organisational reliability.

February 9, 2022

Effects of a refined evidence-based toolkit and mentored implementation on medication reconciliation at 18 hospitals: results of the MARQUIS2 study.

May 19, 2021

The effectiveness of interruptive prescribing alerts in ambulatory CPOE to change prescriber behaviour and improve safety.

May 5, 2021

A realist synthesis of pharmacist-conducted medication reviews in primary care after leaving hospital: what works for whom and why?

December 2, 2020

View More

Related Resources

Improving safety by evaluating the impact of the supply chain and drug shortages on health-systems.

March 29, 2023

The Lancet Commission on lessons for the future from the COVID-19 pandemic.

October 12, 2022

Impact of the COVID-19 pandemic on cancer care: a global collaborative study.

November 11, 2020

National drug shortages worsen during COVID-19 crisis: proposal for a comprehensive model to monitor and address critical drug shortages.

November 4, 2020

For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths.

August 19, 2020

Special report: COVID deepens the other opioid crisis - a shortage of hospital painkillers.

June 24, 2020

Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States.

June 23, 2020

The coronavirus and the risks to the elderly in long-term care.

May 6, 2020

Ensuring access to medications in the US during the COVID-19 pandemic.

May 6, 2020

Spikes in demand from coronavirus patients are creating shortages of asthma drugs and sedatives for ventilator patients.

April 22, 2020

View More

See More About The Topic

Infectious Diseases

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364